Clarithromycin 500 mg Extended Release Tablets Under Non-Fasting Conditions.

NCT00840216 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Clarithromycin ER 500 mg tablets
DRUG: BIAXIN® XL 500 mg tablets

Sponsor

Teva Pharmaceuticals USA